Callan Jmb Inc.

Snapshot

Callan JMB is a tiny logistics company shrinking while losing money: FY 2025 revenue fell 12.8% to $5.7M, and the company lost $8.0M, more than the entire revenue base.

What's Happening Right Now

• Mon 2nd Nov '26 · Manufacturing deal: Callan JMB received a QuickStrip oral thin-film production line from Rapid Dose Therapeutics for its Texas facility and projects up to $15 million in revenue over 18 months, contingent on equipment qualification; management says it won't require additional capital raises.
• Thu 22nd Oct '26 · Facility plan: Callan JMB approved blueprints and set a late-October groundbreaking for a $16 million IV bag manufacturing facility in Marion, Alabama, which it says will be funded by a non-dilutive, non-interest-bearing third-party partnership and projects $450 million in eventual annual revenue.
• Mon 19th Oct '26 · Deal terminated: On Oct 16, 2026, Callan JMB terminated its agreement to acquire 50% of oil and gas leases from The Pfanenstiel Company after diligence was deemed insufficient, removing an anticipated capital-raise need for that deal.
• Fri 16th Oct '26 · Delisting risk: Nasdaq issued a Staff Determination on Oct 12, 2026 after Callan JMB missed its Oct 5 deadline to regain compliance with the $2.5 million minimum stockholders' equity rule; the company requested a hearing, which stays suspension pending the panel's decision.
• Fri 14th Aug '26 · Q2 results: Callan JMB's 10-Q showed Q2 2026 revenue down 17% YoY, a six-month net loss of $4.4 million (up 68%), cash down to $860,273, stockholders' equity of just $681,863, and said going-concern doubt is not alleviated.
• Fri 5th Jun '26 · Registration: Registered $200.00M of securities for sale on Form S-3.
• Mon 22nd Sep '25 · Registration: Registered 6.00M shares for sale on Form S-1.
• Tue 4th Feb '25 · Warrants: Issued warrants over 72K shares.